PaxMedica, Common Stock Price Prediction

PXMDDelisted Stock  USD 0.86  0.18  17.31%   
At the present time, the relative strength index (RSI) of PaxMedica, Common's share price is approaching 34 indicating that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling PaxMedica, Common, making its price go up or down.

Oversold Vs Overbought

34

 
Oversold
 
Overbought
The successful prediction of PaxMedica, Common's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of PaxMedica, Common and does not consider all of the tangible or intangible factors available from PaxMedica, Common's fundamental data. We analyze noise-free headlines and recent hype associated with PaxMedica, Common Stock, which may create opportunities for some arbitrage if properly timed.
Using PaxMedica, Common hype-based prediction, you can estimate the value of PaxMedica, Common Stock from the perspective of PaxMedica, Common response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in PaxMedica, Common to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying PaxMedica, because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

PaxMedica, Common after-hype prediction price

    
  USD 0.86  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Intrinsic
Valuation
LowRealHigh
0.820.820.95
Details
Naive
Forecast
LowNextHigh
0.820.820.82
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.790.840.89
Details

PaxMedica, Common After-Hype Price Prediction Density Analysis

As far as predicting the price of PaxMedica, Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PaxMedica, Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of PaxMedica, Common, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

PaxMedica, Common Estimiated After-Hype Price Volatility

In the context of predicting PaxMedica, Common's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PaxMedica, Common's historical news coverage. PaxMedica, Common's after-hype downside and upside margins for the prediction period are 0.86 and 0.86, respectively. We have considered PaxMedica, Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.86
0.86
After-hype Price
0.86
Upside
PaxMedica, Common is very steady at this time. Analysis and calculation of next after-hype price of PaxMedica, Common Stock is based on 3 months time horizon.

PaxMedica, Common Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as PaxMedica, Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PaxMedica, Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PaxMedica, Common, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
11 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.86
0.86
0.00 
0.00  
Notes

PaxMedica, Common Hype Timeline

PaxMedica, Common Stock is at this time traded for 0.86. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. PaxMedica, is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on PaxMedica, Common is about 0.0%, with the expected price after the next announcement by competition of 0.86. The company has price-to-book ratio of 1.84. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PaxMedica, Common Stock recorded a loss per share of 11.0. The entity had not issued any dividends in recent years. The firm had 1:17 split on the 31st of October 2023. Given the investment horizon of 90 days the next expected press release will be within a week.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

PaxMedica, Common Related Hype Analysis

Having access to credible news sources related to PaxMedica, Common's direct competition is more important than ever and may enhance your ability to predict PaxMedica, Common's future price movements. Getting to know how PaxMedica, Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PaxMedica, Common may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
QNRXQuoin Pharmaceuticals Ltd 0.01 10 per month 6.53  0.04  17.65 (9.68) 74.46 
BWVBWV(0.01)2 per month 2.98  0.02  4.26 (4.72) 68.28 
REVBRevelation Biosciences(0.03)3 per month 0.00 (0.1) 8.97 (7.83) 34.52 
HILSHillstream Biopharma 0.03 3 per month 0.00 (0.06) 8.33 (7.89) 113.15 
UNCYUnicycive Therapeutics(0.05)7 per month 4.13  0.20  10.26 (7.32) 29.22 
CDIOCardio Diagnostics Holdings(0.01)3 per month 6.76 (0.01) 14.81 (13.16) 57.04 
VRAXVirax Biolabs Group(0.81)3 per month 0.00 (0.12) 9.65 (12.90) 61.28 
ALLRAllarity Therapeutics 0.07 10 per month 0.00 (0.27) 10.85 (16.11) 41.48 
KRBPKiromic Biopharma(0.24)3 per month 0.00 (0.03) 12.04 (10.96) 65.24 
BDRXBiodexa Pharmaceticals 0.40 9 per month 0.00 (0.08) 13.30 (17.24) 97.78 
KPRXKiora Pharmaceuticals(0.15)6 per month 0.00 (0.08) 5.95 (4.97) 16.59 
ZVSAZyVersa Therapeutics(0.01)5 per month 0.00 (0.15) 7.57 (9.60) 78.93 
PALIPalisade Bio 0.03 6 per month 0.00 (0.12) 5.97 (8.55) 24.25 
APGNApexigen(0.02)5 per month 5.50 (0) 7.89 (11.11) 58.79 
IMMXImmix Biopharma(0.04)4 per month 4.54 (0.01) 9.38 (8.22) 32.68 

PaxMedica, Common Additional Predictive Modules

Most predictive techniques to examine PaxMedica, price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PaxMedica, using various technical indicators. When you analyze PaxMedica, charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About PaxMedica, Common Predictive Indicators

The successful prediction of PaxMedica, Common stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PaxMedica, Common Stock, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PaxMedica, Common based on analysis of PaxMedica, Common hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PaxMedica, Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PaxMedica, Common's related companies.

Story Coverage note for PaxMedica, Common

The number of cover stories for PaxMedica, Common depends on current market conditions and PaxMedica, Common's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PaxMedica, Common is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PaxMedica, Common's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

PaxMedica, Common Short Properties

PaxMedica, Common's future price predictability will typically decrease when PaxMedica, Common's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of PaxMedica, Common Stock often depends not only on the future outlook of the potential PaxMedica, Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PaxMedica, Common's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.7 M
Cash And Short Term Investments4.7 M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in PaxMedica, Pink Sheet

If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
CEOs Directory
Screen CEOs from public companies around the world